Pharma Journalist -

Roche announced that the company is voluntarily withdrawing the US indication for Tecentriq (atezolizumab) in prior-platinum treated metastatic urothelial carcinoma (mUC, bladder…
Read More...

SMi Reports: SMi Group are delighted to invite you to attend the Injectable Drug Delivery which is returning on 12th - 13th May 2021 as a virtual Conference. Following on from the…
Read More...

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics, LP announced preliminary results from Ridgeback’s Phase 2a randomized, double-blind,…
Read More...

Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced it has enrolled…
Read More...

Eli Lilly and Company announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for…
Read More...

SMi Group Reports: Just under two weeks remaining until the 2nd Annual AI in Drug Delivery Conference takes place as a virtual conference on 15 and 16 March 2021. The conference is…
Read More...

EMA’s human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and…
Read More...

ConserV Bioscience Limited a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and eTheRNA…
Read More...

Eisai Co., Ltd. announced that it has decided to assent to and support a project led by CA Medlynks Kenya, Ltd. (Headquarters: Nairobi), a subsidiary of the healthcare startup company…
Read More...

Amgen and Five Prime Therapeutics a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, announced an agreement under which Amgen…
Read More...